Sonic Incytes Medical Corp.

Sonic Incytes is developing accessible solutions that provide health insights to enhance patient care. In response to the global rise in fatty liver disease, Sonic Incytes has introduced Velacur, a novel point-of-care ultrasound-based liver imaging solution that utilizes S-WAVE technology. Combining elements of MRE, shear wave ultrasound, and liver visualization, Velacur accurately quantifies elasticity and attenuation to aid in the clinical management of patients with chronic liver disease.